SCHEMBL20063086

SCHEMBL20063086

CC(C)C1=Nc2ccccc2Oc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.55
CYP2D6 P10635 3/20 0.55
HRH4 Q9H3N8 6/20 0.46
MAPK1 P28482 2/20 0.45
DRD2 P14416 4/20 0.40
HRH2 P25021 3/20 0.40
HRH1 P35367 3/20 0.40
DRD4 P21917 3/20 0.40
HTR2C P28335 3/20 0.40
DRD3 P35462 3/20 0.40
ADRB2 P07550 2/20 0.40
CHRM2 P08172 2/20 0.40
CHRM4 P08173 2/20 0.40
HTR1A P08908 2/20 0.40
CHRM5 P08912 2/20 0.40
ADRA2A P08913 2/20 0.40
ADORA3 P0DMS8 2/20 0.40
CHRM1 P11229 2/20 0.40
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25874636 0.84 MAPT (0.39) CYP1A2CYP2D6HRH4MAPK1KDM4E
SCHEMBL12208495 0.84 MAPK1 (0.56) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL25671325 0.84 MAPK1 (0.46) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL10990205 0.83 CYP1A2 (0.49) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL1773258 0.75 MAPK1 (0.67) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL5438458 0.74 CYP1A2 (0.55) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL18085896 0.74 HDAC3 (0.56) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL1772873 0.71 CYP1A2 (0.60) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL10059990 0.71 CYP1A2 (1.00) CYP1A2CYP2D6HRH4MAPK1DRD2
SCHEMBL311434 0.71 CYP1A2 (0.60) CYP1A2CYP2D6HRH4MAPK1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-01-18 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof PHGDH, PGD, PGK1 CYP1A2 1301/4885CYP2D6 429/4885HRH4 201/4885
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 CYP1A2 1449/4885CYP2D6 564/4885HRH4 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.